启明医疗-B(02500):Cardiovalve经导管三尖瓣置换系统递交CE MDR认证申请

智通财经
Dec 24, 2025

智通财经APP讯,启明医疗-B(02500)发布公告,于近日,集团已就Cardiovalve经导管三尖瓣置换系统(Cardiovalve系统)正式向欧洲公告机构递交CE MDR认证的全部申请资料。

Cardiovalve系统是一款同时可用于治疗二尖瓣反流和三尖瓣反流的经导管介入置换产品。与同类产品相比,Cardiovalve系统经股静脉的入路方式显著提升了治疗安全性,产品最大55mm的大瓣环设计适用约95%的患者群体,同时,其独特的短瓣架设计可有效降低心室流出道梗阻风险。Cardiovalve系统操作简单、安全、可复制性强,只需定位、锚定、释放三个步骤完成。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10